July 14th 2021
This activity will examine the pathophysiology of cystic fibrosis and the complications associated with disease progression.
January 10th 2021
This article will describe the role of genomic testing in therapy selection in the treatment of patients with metastatic triple-negative breast cancer (TNBC).
July 10th 2021
Through this activity, specialty pharmacists will become familiar with the current IPF treatment paradigm and receive practice pearls for improving patient care and outcomes.
This activity will review the approval process and required nomenclature for biosimilars as well as the differences between biosimilars and biologics.
This session will examine the evidence regarding the association between thrombosis and COVID-19.
July 8th 2021
This activity will examine the epidemiology, pathophysiology, clinical presentation, and diagnosis of spinal muscular atrophy (SMA).
July 7th 2021
This activity will examine the pathophysiology of chronic inflammatory demyelinating polyneuropathy (CIDP).
July 6th 2021
This activity will review the novel mechanisms of action of emerging agents in the MS treatment landscape, as well as new long-term data that has implications in treatment decisions for patients with MS.
July 1st 2021
Featured in this technician activity are patient counseling video vignettes, which will provide important educational points and follow a patient’s journey in learning more about CGM.
Featured in this activity are patient counseling video vignettes, which will provide important educational points and follow a patient’s journey in learning more about CGM.
